XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Pay vs Performance Disclosure - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Pay vs Performance Disclosure      
Pay vs Performance Disclosure, Table
Pay Versus Performance Disclosure
As required by Item 402(v) of Regulation
S-K,
this section discusses the relationship between executive compensation and
the
Company’s financial performance for each of the last three completed calendar years. In determining the “compensation actually paid” to our NEOs, we are required to make various adjustments to amounts that have been previously reported in the Summary Compensation Table in previous years, as the SEC’s valuation methods for this section differ from those required in the Summary Compensation Table. The table below summarizes compensation values both previously reported in our Summary Compensation Table, as well as the adjusted values required in this section for each of the fiscal years ended December 31, 2021, 2022 and 2023. Note that for our NEOs other than our current and prior principal executive officers (each, a “PEO”), compensation is reported as an average.
 
Year
  
Summary
Compensation
Table Total for
PEO
(1)

($)
    
Compensation
Actually Paid
to PEO
(1)(2)

($)
    
Average
Summary
Compensation
Table Total for
Non-PEO

NEOs
(1)

($)
    
Average
Compensation
Actually Paid
to Non-PEO

NEOs
(1)(2)

($)
    
Value of Initial Fixed $100 Investment
Based On:
    
Net Income

(Loss)
(4)

($)
    
Basic

EPS
(5)

($)
  
 
Total

Shareholder

Return
(3)

($)
  
Peer Group
Total
Shareholder
Return
(3)

($)
  
2023
     868,648       1,063,033       1,125,031       1,161,345       129          94       179,722,000       2.75  
2022
     1,798,966       7,127       665,254       497,932       94          114       220,262,000       3.07  
2021
     1,271,138       1,246,717       614,262       561,101       122          126       368,837,000       3.24  
 
(1)
Mr. Raifeld has served as our Chief Executive Officer since May 20, 2020, and the dollar amounts reported for our PEO for fiscal years 2021, 2022 and 2023 reflect amounts for Mr. Raifeld.
The dollar amounts reported for our
Non-PEO
NEOs for fiscal year 2021 reflect the amounts for Ms. Zhen, our only
non-PEO
NEO for such fiscal years. The dollar amount reported for our
non-PEO
NEOs for fiscal year 2022 is the average of the amounts for Ms. Zhen and Mr. Edwards. Mr. Edwards became an NEO on August 22, 2022 and the amount took into consideration only compensation paid by the registrant following such date. The dollar amounts reported for our
Non-PEO
NEOs for fiscal year 2023 reflect the amounts for Ms. Zhen and Mr. Basso.
 
(2)
The dollar amounts reported in these columns represent the amount of “compensation actually paid” to our NEOs as computed in accordance with Item 402(v) of Regulation
S-K.
The dollar amounts do not reflect the actual amount of compensation earned by or paid to our NEOs during the applicable fiscal year. In accordance with the requirements of Item 402(v) of Regulation
S-K,
the following adjustments were made to the total compensation reported for our NEOs in the “Total” column of the Summary Compensation Table to determine the amount of “compensation actually paid” for each year. NEOs do not participate in a defined benefit plan so no adjustment for pension benefits is included in the table below.
 
    
Year
     
Summary Compensation
Table Total
($)

(a)
     
Reported Value of
Equity Awards
(a)

($)

(b)
     
Equity Award
Adjustment
(b)

($)

(c)
    
Compensation
Actually Paid
($)

(a – b + c)
  
Pavel Raifeld
      2023        868,648        —         194,385       1,063,033  
     2022        1,798,966        1,044,300        (747,539 )      7,127  
     2021        1,271,138        580,330        555,909       1,246,717  
Non-PEO
NEOs
      2023        4,500,122        1,481,214        1,626,471       4,645,379  
     2022        1,330,507        240,922        (93,721 )      995,864  
     2021        614,262        152,086        98,925       561,101  
 
(a)
The grant date fair value of equity awards represents the total of the amounts reported in the “Stock Awards” and “Option Awards” columns, as applicable, in the Summary Compensation Table for the applicable year.
(b)
The equity award adjustment for each applicable year include the addition (or subtraction, as applicable) of the amounts set forth in the table below in accordance with Item 402(v) of Regulation
S-K.
The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant.
 
   
Year
    
Year End Fair
Value of
Outstanding
and Unvested
Equity
Awards
Granted in the
Year
($)
    
Year over Year
Change in Fair
Value of
Outstanding
and Unvested
Equity Awards
Granted in
Prior Years
($)
    
Fair Value as
of Vesting
Date of Equity
Awards
Granted and
Vested in the
Year


($)
    
Year over Year
Change in Fair
Value of Equity
Awards
Granted in
Prior Years that
Vested in the
Year
($)
    
Fair Value at the
End of the Prior
Year of Equity
Awards that Failed
to Meet Vesting
Conditions in the
Year


($)
    
Value of Dividends or
other Earnings Paid
on Stock or Option
Awards not
Otherwise Reflected
in Fair Value or Total
Compensation


($)
    
Total
Equity
Award
Adjustment
($)
  
Pavel Raifeld
     2023       —        224,616       —        (30,231 )      —        —        194,385  
    2022       (340,558 )      (435,147 )      —        28,166       —        —        (747,539 ) 
    2021       224,504       405,433       —        (74,028 )      —        —        555,909  
Non-PEO
NEOs
     2023       1,598,631       32,602       —        (4,761 )      —        —        1,626,471  
    2022       (89,766 )      (44,131 )      —        40,176       —        —        (93,721 ) 
    2021       67,900       38,700       —        (7,675 )      —        —        98,925  
 
(3)
The dollar amounts disclosed in these columns assume $100 was invested for the cumulative period through the end of the list fiscal year, in either the Company or the NASDAQ Biotechnology Index (weighted according to the respective companies’ stock market capitalization at the beginning of each period for which a return is indicated), as applicable, and reinvestment of the
pre-tax
value of dividends paid. Historical stock performance is not necessarily indicative of future stock performance.
(4)
The dollar amounts reported in this column represent the amount of net income (loss) previously disclosed in our consolidated audited financial statements for the applicable year, as required by Regulation
S-X.
(5)
While the Company uses a number of financial performance measures for the purpose of evaluating performance for the Company’s compensation programs, the Company has determined that basic earnings per share (EPS) is the financial performance measure that, in the Company’s assessment, represents the most important performance measure (that is not otherwise required to be disclosed in the table) used by the Company to link compensation actually paid to the Company’s NEOs, for the most recently completed fiscal year, to the Company’s performance.
   
Company Selected Measure Name BasicEPS    
Named Executive Officers, Footnote The dollar amounts reported for our
Non-PEO
NEOs for fiscal year 2021 reflect the amounts for Ms. Zhen, our only
non-PEO
NEO for such fiscal years. The dollar amount reported for our
non-PEO
NEOs for fiscal year 2022 is the average of the amounts for Ms. Zhen and Mr. Edwards. Mr. Edwards became an NEO on August 22, 2022 and the amount took into consideration only compensation paid by the registrant following such date. The dollar amounts reported for our
Non-PEO
NEOs for fiscal year 2023 reflect the amounts for Ms. Zhen and Mr. Basso. 		   
Peer Group Issuers, Footnote The dollar amounts disclosed in these columns assume $100 was invested for the cumulative period through the end of the list fiscal year, in either the Company or the NASDAQ Biotechnology Index (weighted according to the respective companies’ stock market capitalization at the beginning of each period for which a return is indicated), as applicable, and reinvestment of the
pre-tax
value of dividends paid. Historical stock performance is not necessarily indicative of future stock performance. 		   
PEO Total Compensation Amount $ 868,648 $ 1,798,966 $ 1,271,138
PEO Actually Paid Compensation Amount $ 1,063,033 7,127 1,246,717
Adjustment To PEO Compensation, Footnote
(2)
The dollar amounts reported in these columns represent the amount of “compensation actually paid” to our NEOs as computed in accordance with Item 402(v) of Regulation
S-K.
The dollar amounts do not reflect the actual amount of compensation earned by or paid to our NEOs during the applicable fiscal year. In accordance with the requirements of Item 402(v) of Regulation
S-K,
the following adjustments were made to the total compensation reported for our NEOs in the “Total” column of the Summary Compensation Table to determine the amount of “compensation actually paid” for each year. NEOs do not participate in a defined benefit plan so no adjustment for pension benefits is included in the table below.
 
    
Year
     
Summary Compensation
Table Total
($)

(a)
     
Reported Value of
Equity Awards
(a)

($)

(b)
     
Equity Award
Adjustment
(b)

($)

(c)
    
Compensation
Actually Paid
($)

(a – b + c)
  
Pavel Raifeld
      2023        868,648        —         194,385       1,063,033  
     2022        1,798,966        1,044,300        (747,539 )      7,127  
     2021        1,271,138        580,330        555,909       1,246,717  
Non-PEO
NEOs
      2023        4,500,122        1,481,214        1,626,471       4,645,379  
     2022        1,330,507        240,922        (93,721 )      995,864  
     2021        614,262        152,086        98,925       561,101  
 
(a)
The grant date fair value of equity awards represents the total of the amounts reported in the “Stock Awards” and “Option Awards” columns, as applicable, in the Summary Compensation Table for the applicable year.
(b)
The equity award adjustment for each applicable year include the addition (or subtraction, as applicable) of the amounts set forth in the table below in accordance with Item 402(v) of Regulation
S-K.
The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant.
 
   
Year
    
Year End Fair
Value of
Outstanding
and Unvested
Equity
Awards
Granted in the
Year
($)
    
Year over Year
Change in Fair
Value of
Outstanding
and Unvested
Equity Awards
Granted in
Prior Years
($)
    
Fair Value as
of Vesting
Date of Equity
Awards
Granted and
Vested in the
Year


($)
    
Year over Year
Change in Fair
Value of Equity
Awards
Granted in
Prior Years that
Vested in the
Year
($)
    
Fair Value at the
End of the Prior
Year of Equity
Awards that Failed
to Meet Vesting
Conditions in the
Year


($)
    
Value of Dividends or
other Earnings Paid
on Stock or Option
Awards not
Otherwise Reflected
in Fair Value or Total
Compensation


($)
    
Total
Equity
Award
Adjustment
($)
  
Pavel Raifeld
     2023       —        224,616       —        (30,231 )      —        —        194,385  
    2022       (340,558 )      (435,147 )      —        28,166       —        —        (747,539 ) 
    2021       224,504       405,433       —        (74,028 )      —        —        555,909  
Non-PEO
NEOs
     2023       1,598,631       32,602       —        (4,761 )      —        —        1,626,471  
    2022       (89,766 )      (44,131 )      —        40,176       —        —        (93,721 ) 
    2021       67,900       38,700       —        (7,675 )      —        —        98,925  
    
Non-PEO NEO Average Total Compensation Amount $ 1,125,031 665,254 614,262
Non-PEO NEO Average Compensation Actually Paid Amount $ 1,161,345 497,932 561,101
Adjustment to Non-PEO NEO Compensation Footnote
(2)
The dollar amounts reported in these columns represent the amount of “compensation actually paid” to our NEOs as computed in accordance with Item 402(v) of Regulation
S-K.
The dollar amounts do not reflect the actual amount of compensation earned by or paid to our NEOs during the applicable fiscal year. In accordance with the requirements of Item 402(v) of Regulation
S-K,
the following adjustments were made to the total compensation reported for our NEOs in the “Total” column of the Summary Compensation Table to determine the amount of “compensation actually paid” for each year. NEOs do not participate in a defined benefit plan so no adjustment for pension benefits is included in the table below.
 
    
Year
     
Summary Compensation
Table Total
($)

(a)
     
Reported Value of
Equity Awards
(a)

($)

(b)
     
Equity Award
Adjustment
(b)

($)

(c)
    
Compensation
Actually Paid
($)

(a – b + c)
  
Pavel Raifeld
      2023        868,648        —         194,385       1,063,033  
     2022        1,798,966        1,044,300        (747,539 )      7,127  
     2021        1,271,138        580,330        555,909       1,246,717  
Non-PEO
NEOs
      2023        4,500,122        1,481,214        1,626,471       4,645,379  
     2022        1,330,507        240,922        (93,721 )      995,864  
     2021        614,262        152,086        98,925       561,101  
 
(a)
The grant date fair value of equity awards represents the total of the amounts reported in the “Stock Awards” and “Option Awards” columns, as applicable, in the Summary Compensation Table for the applicable year.
(b)
The equity award adjustment for each applicable year include the addition (or subtraction, as applicable) of the amounts set forth in the table below in accordance with Item 402(v) of Regulation
S-K.
The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant.
 
   
Year
    
Year End Fair
Value of
Outstanding
and Unvested
Equity
Awards
Granted in the
Year
($)
    
Year over Year
Change in Fair
Value of
Outstanding
and Unvested
Equity Awards
Granted in
Prior Years
($)
    
Fair Value as
of Vesting
Date of Equity
Awards
Granted and
Vested in the
Year


($)
    
Year over Year
Change in Fair
Value of Equity
Awards
Granted in
Prior Years that
Vested in the
Year
($)
    
Fair Value at the
End of the Prior
Year of Equity
Awards that Failed
to Meet Vesting
Conditions in the
Year


($)
    
Value of Dividends or
other Earnings Paid
on Stock or Option
Awards not
Otherwise Reflected
in Fair Value or Total
Compensation


($)
    
Total
Equity
Award
Adjustment
($)
  
Pavel Raifeld
     2023       —        224,616       —        (30,231 )      —        —        194,385  
    2022       (340,558 )      (435,147 )      —        28,166       —        —        (747,539 ) 
    2021       224,504       405,433       —        (74,028 )      —        —        555,909  
Non-PEO
NEOs
     2023       1,598,631       32,602       —        (4,761 )      —        —        1,626,471  
    2022       (89,766 )      (44,131 )      —        40,176       —        —        (93,721 ) 
    2021       67,900       38,700       —        (7,675 )      —        —        98,925  
    
Compensation Actually Paid vs. Total Shareholder Return
   
Compensation Actually Paid vs. Net Income
   
Compensation Actually Paid vs. Company Selected Measure
   
Total Shareholder Return Vs Peer Group
   
Tabular List, Table
Performance Measures
The following list includes the financial performance measures used by the Company to link compensation actually paid to our NEOs to the performance of the Company for the fiscal year ended December 31, 2023. These measures are not ranked.
 
  •  
Basic EPS
 
  •  
Gross Revenue
 
  •  
Amount of Capital Allocation Activities
   
Total Shareholder Return Amount $ 129 94 122
Peer Group Total Shareholder Return Amount 94 114 126
Net Income (Loss) $ 179,722,000 $ 220,262,000 $ 368,837,000
Company Selected Measure Amount 2.75 3.07 3.24
PEO Name Mr. Raifeld Mr. Raifeld Mr. Raifeld
NonPEO NEO Average Total Compensation Amount $ 4,500,122 $ 1,330,507  
NonPEO NEO Average Compensation Actually Paid Amount $ 4,645,379 995,864  
Measure:: 1      
Pay vs Performance Disclosure      
Name Basic EPS    
Measure:: 2      
Pay vs Performance Disclosure      
Name Gross Revenue    
Measure:: 3      
Pay vs Performance Disclosure      
Name Amount of Capital Allocation Activities    
PEO | Reported Value of Equity Awards [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount   1,044,300 $ 580,330
PEO | Equity Award Adjustment [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount $ 194,385 (747,539) 555,909
PEO | Year End Fair Value of Outstanding and Unvested Equity Awards Granted in the Year [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount   (340,558) 224,504
PEO | Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount 224,616 (435,147) 405,433
PEO | Year over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount (30,231) 28,166 (74,028)
Non-PEO NEO | Reported Value of Equity Awards [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount 1,481,214 240,922 152,086
Non-PEO NEO | Equity Award Adjustment [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount 1,626,471 (93,721) 98,925
Non-PEO NEO | Year End Fair Value of Outstanding and Unvested Equity Awards Granted in the Year [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount 1,598,631 (89,766) 67,900
Non-PEO NEO | Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount 32,602 (44,131) 38,700
Non-PEO NEO | Year over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount $ (4,761) $ 40,176 $ (7,675)